Transarterial Radioembolization (TARE) is a sophisticated palliative option for treating liver cancers, such as Hepatocellular Carcinoma (HCC) and Cholangiocarcinoma.
A PICC line, or peripherally inserted central catheter, is a slender, flexible tube inserted into a vein in the arm, leg, or neck, with its tip positioned in a major vein near the heart.
TACE is a minimally invasive procedure used to treat liver cancer. It involves delivering chemotherapy directly into the tumor’s blood vessels along with a blocking agent to cut off its blood supply.
Microwave ablation (MWA) is a minimally invasive technique that uses microwave energy to destroy cancerous tumors. It is an excellent option for patients who are not candidates for surgery or have tumors that are too large or challenging to remove surgically.
PTBD is a medical procedure used to diagnose or treat bile duct obstructions. The goal is to identify the site of the blockage and/or place a temporary catheter to drain bile. This procedure is ideal for patients seeking to avoid surgery or those for whom surgery poses significant risks, as it typically involves fewer complications than surgical options.
TARE (Transarterial Radioembolization (TARE)-
Transarterial Radioembolization (TARE) is a sophisticated palliative option for treating liver cancers, such as Hepatocellular Carcinoma (HCC) and Cholangiocarcinoma. This technique merges radiation therapy with embolization, using radioactive microspheres to obstruct blood flow to tumors while delivering targeted radiation. It is particularly beneficial for patients who cannot undergo surgery or liver transplantation. The process begins with hepatic angiography to plan and simulate the treatment, followed by the injection of the radioactive particles.
TARE can address both large and multiple tumors in the liver and is generally better tolerated compared to Transarterial Chemoembolization (TACE), resulting in fewer serious side effects. After the procedure, patients usually remain in the hospital for two to three days due to temporary radioactivity. Complications are infrequent, which makes TARE a hopeful choice for those suffering from advanced liver cancer.